Source: Big Think
Jill Inverso, MS, PhD, holds degrees in the areas of immunology and infectious diseases. She has over 25 years of combined experience in academic medical research and pharmaceutical R&D. She is currently the Executive Director, Disease Area Lead – Infectious Diseases in the Specialty Care Business Unit at Pfizer.
- Antimicrobial drugs are losing their effectiveness because pathogens change and find ways to resist the effects of antibiotics, leading to the development of superbugs.
- Antimicrobial resistance (AMR) causes 700,000 deaths annually across the globe, a number that is projected to skyrocket to 10 million by the year 2050 if…
The post How the global health community is fighting the rise of superbugs appeared first on FeedBox.